ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

MBIO Mustang Bio Inc

0.29883
0.03873 (14.89%)
Última actualización: 14:44:17
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Mustang Bio Inc MBIO NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.03873 14.89% 0.29883 14:44:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.2699 0.2699 0.2999 0.2601
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/4/202419:00GLOBEMustang Bio Announces Pricing of $4 Million Public Offering
28/3/202408:00GLOBEMustang Bio Announces Vision for CAR T-Cell Therapy Platform..
11/3/202415:30EDGAR2Form 8-K - Current report
11/3/202415:05GLOBEMustang Bio Reports Full-Year 2023 Financial Results and..
11/3/202415:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202406:30GLOBEMustang Bio Announces Publication in Nature Medicine of Data..
14/2/202415:15EDGAR2Form 8-K - Current report
25/1/202415:07EDGAR2Form 8-K - Current report
11/1/202407:30GLOBEMustang Bio to Participate in the B. Riley Securities 4th..
04/1/202415:05EDGAR2Form 8-K - Current report
19/12/202315:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/12/202320:52EDGAR2Form S-1 - General form for registration of securities under..
11/12/202307:37EDGAR2Form 8-K - Current report
11/12/202307:30GLOBEMustang Bio Presents Updated Phase 1/2 Multicenter Clinical..
14/11/202315:44EDGAR2Form 8-K - Current report
14/11/202315:05GLOBEMustang Bio Reports Third Quarter 2023 Financial Results and..
03/11/202314:22EDGAR2Form D - Notice of Exempt Offering of Securities
02/11/202315:05EDGAR2Form 8-K - Current report
02/11/202308:28GLOBEMustang Bio Announces MB-106 CD20-Targeted CAR-T Data..
30/10/202313:57EDGAR2Form 8-K - Current report
30/10/202313:15GLOBEMustang Bio Announces Closing of $4.4 Million Registered..
30/10/202309:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
26/10/202315:05EDGAR2Form 8-K - Current report
26/10/202311:30GLOBEMustang Bio Announces $4.4 Million Registered Direct..
26/10/202308:00GLOBEMustang Bio Announces FDA Acceptance of IND Application for..
04/10/202315:05EDGAR2Form 8-K - Current report
16/8/202307:56EDGAR2Form 8-K - Current report
14/8/202315:10EDGAR2Form 8-K - Current report
14/8/202315:01GLOBEFortress Biotech Reports Second Quarter 2023 Financial..
14/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202307:40EDGAR2Form 8-K - Current report
20/7/202316:30EDGAR2Form 8-K - Current report
11/7/202307:05EDGAR2Form 8-K - Current report
07/7/202315:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202307:05EDGAR2Form 8-K - Current report
15/5/202315:01GLOBEFortress Biotech Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock